The MTPC panel integrated four diagnostic modalities: methylation biomarkers (PTGER4 and SHOX2), tumor markers (CEA and CYFRA21-1), DNA ploidy analysis, and cytological examination. The gene discussed is PTGER4; the disease is neoplasm.